Current market catalysts

8-K filing — INVO Fertility, Inc. (IVF)

Filed: 2026-08-28 AccNo: 0001493152-26-040504 Size: 11 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — Aprea Therapeutics, Inc. (APRE)

Filed: 2026-08-28 AccNo: 0001104659-26-102795 Size: 182 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — UNIFIRST CORP (UNF)

Filed: 2026-08-28 AccNo: 0001193125-26-372350 Size: 133 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

8-K filing — United States Commodity Index Funds Trust (CPER)

Filed: 2026-08-28 AccNo: 0001104659-26-102792 Size: 286 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — United States Brent Oil Fund, LP (BNO)

Filed: 2026-08-28 AccNo: 0001104659-26-102791 Size: 207 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Cantor Fitzgerald Maintains Neutral on Elastic, Raises Price Target to $100

8-K filing — United States 12 Month Natural Gas Fund, LP (UNL)

Filed: 2026-08-28 AccNo: 0001104659-26-102790 Size: 207 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

What's Going On With SentinelOne Stock Friday?

SentinelOne shares are trading lower Friday after it reported Q2 results Thursday and lowered its FY27 adjusted EPS guidance below estimates.

8-K filing — United States Gasoline Fund, LP (UGA)

Filed: 2026-08-28 AccNo: 0001104659-26-102789 Size: 206 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — United States 12 Month Oil Fund, LP (USL)

Filed: 2026-08-28 AccNo: 0001104659-26-102788 Size: 206 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — United States Natural Gas Fund, LP (UNG)

Filed: 2026-08-28 AccNo: 0001104659-26-102787 Size: 208 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — United States Oil Fund, LP (USO)

Filed: 2026-08-28 AccNo: 0001104659-26-102786 Size: 211 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Cantor Fitzgerald Reiterates Overweight on IREN, Maintains $99 Price Target

These Analysts Revise Their Forecasts On Workday Following Q2 Results

Workday reported strong Q2 results, but lowered its FY27 sales guidance. Analysts have mixed opinions on stock. WDAY shares rose in pre-market trading.

'China's Financial Regulators Extends Mortgage Term From 30 to 40 Years' - TMTPost

Cantor Fitzgerald Reiterates Overweight on Rubrik, Maintains $120 Price Target

Cantor Fitzgerald analyst Jonathan Ruykhaver reiterates Rubrik (NYSE:RBRK) with a Overweight and maintains $120 price target.

Cantor Fitzgerald Maintains Overweight on Workday, Lowers Price Target to $205

Cantor Fitzgerald analyst Matthew Vanvliet maintains Workday (NASDAQ:WDAY) with a Overweight and lowers the price target from $220 to $205.

Morgan Stanley Maintains Overweight on Burlington Stores, Lowers Price Target to $432

Morgan Stanley analyst Alex Straton maintains Burlington Stores (NYSE:BURL) with a Overweight and lowers the price target from $438 to $432.

Morgan Stanley Maintains Underweight on PagerDuty, Raises Price Target to $10

Morgan Stanley analyst Sanjit Singh maintains PagerDuty (NYSE:PD) with a Underweight and raises the price target from $9 to $10.

Cantor Fitzgerald Reiterates Overweight on SentinelOne, Maintains $26 Price Target

Cantor Fitzgerald analyst Jonathan Ruykhaver reiterates SentinelOne (NYSE:S) with a Overweight and maintains $26 price target.

Tenon Medical Prices $3M Private Placement Offering Of 1,058,517 Shares At $5.02 Per Share And Accompanying Warrants

Aprea Therapeutics Expands Current Patent Portfolio

Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea", or the "Company"), a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with

Amarin Says REDUCE-IT Post Hoc Analysis Showed About 30% Relative Risk Reduction In Major Adverse Cardiovascular Events Among Patients On Icosapent Ethyl At Least 1.5 Years; Hazard Ratio Of 0.73 Persisted After Discontinuation

Morgan Stanley Maintains Underweight on Workday, Raises Price Target to $180

Morgan Stanley analyst Keith Weiss maintains Workday (NASDAQ:WDAY) with a Underweight and raises the price target from $145 to $180.

Morgan Stanley Maintains Equal-Weight on Affirm Holdings, Raises Price Target to $82

Morgan Stanley analyst James Faucette maintains Affirm Holdings (NASDAQ:AFRM) with a Equal-Weight and raises the price target from $80 to $82.

Should State Street SPDR Portfolio S&P 600 Small Cap ETF (SPSM) Be on Your Investing Radar?

SPSM, a passively managed small-cap blend ETF with $17.09 billion in assets, offers broad exposure to the US small-cap market with an extremely low expense ratio of 0.03%. The fund has gained 22.55% year-to-date and 25.02% over the past year, earning a Zacks ETF Rank of 1 (Strong Buy). With 610 holdings and a beta of 1.02, it provides effective diversification for long-term investors seeking small-cap exposure.

Is Invesco S&P MidCap 400 Pure Value ETF (RFV) a Strong ETF Right Now?

The Invesco S&P MidCap 400 Pure Value ETF (RFV) is a smart beta ETF offering mid-cap value exposure with a 0.35% expense ratio and $337.73 million in assets. The fund has gained 17.9% year-to-date with a 1.22% dividend yield but carries higher risk with a beta of 1.05 and 20.20% standard deviation. Top holdings include PBF Energy, Avnet, and Arrow Electronics, with heavy Consumer Discretionary sector exposure at 20.7%.

Should Janus Henderson Small Cap Growth Alpha ETF (JSML) Be on Your Investing Radar?

Janus Henderson Small Cap Growth Alpha ETF (JSML) is a passively managed ETF offering exposure to small-cap growth stocks with a 0.3% expense ratio and $378 million in assets. The fund has delivered strong year-to-date returns of 23.06% and holds 122 diversified holdings with heavy healthcare sector exposure. It received a Zacks ETF Rank of 2 (Buy), though investors should consider alternatives like IWO and VBK which offer lower expense ratios.

Should Goldman Sachs ActiveBeta U.S. Large Cap Equity ETF (GSLC) Be on Your Investing Radar?

GSLC is a passively managed large-cap blend ETF with $15.28 billion in assets and a very low expense ratio of 0.09%. The fund has delivered 11.79% year-to-date returns and 17.05% over the past year, with significant exposure to technology stocks including Nvidia, Apple, and Microsoft. It carries a Zacks ETF Rank of 3 (Hold), positioning it as a sufficient but not exceptional option compared to competitors like VOO and IVV.

Should John Hancock Multifactor Small Cap ETF (JHSC) Be on Your Investing Radar?

John Hancock Multifactor Small Cap ETF (JHSC) is a passively managed small-cap blend ETF with $734 million in assets and a 0.42% expense ratio. The fund has returned 17.09% year-to-date and 18.14% over the past year, with 502 holdings providing diversification. It carries a Zacks ETF Rank of 3 (Hold), making it a reasonable option for small-cap exposure, though competitors like Vanguard Morningstar Small-Cap ETF and iShares Core S&P Small-Cap ETF offer lower expense ratios.